Abbott Laboratories (ABT)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 81,414,000 74,356,000 73,017,000 72,467,000 73,214,000 72,090,000 73,354,000 73,794,000 74,438,000 72,801,000 74,202,000 74,007,000 75,196,000 73,795,000 73,269,000 72,785,000 72,548,000 69,043,000 68,793,000 66,712,000
Total stockholders’ equity US$ in thousands 47,664,000 39,796,000 39,318,000 38,810,000 38,603,000 37,481,000 37,174,000 74,219,000 36,686,000 35,675,000 36,490,000 35,399,000 35,802,000 34,422,000 33,800,000 33,562,000 32,784,000 31,386,000 30,578,000 30,218,000
Financial leverage ratio 1.71 1.87 1.86 1.87 1.90 1.92 1.97 0.99 2.03 2.04 2.03 2.09 2.10 2.14 2.17 2.17 2.21 2.20 2.25 2.21

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $81,414,000K ÷ $47,664,000K
= 1.71

The financial leverage ratio of Abbott Laboratories has shown a downward trend from March 31, 2022, to December 31, 2024. The ratio decreased from 2.09 to 1.71 during this period. This indicates that Abbott Laboratories has been reducing its reliance on debt to finance its operations and investments. A lower financial leverage ratio suggests lower financial risk and more stability in the company's capital structure. Investors and creditors may view a decreasing financial leverage ratio positively as it signifies improved financial health and strength of the company. Abbott Laboratories' management may have been managing their debt levels effectively to ensure sustainable growth and profitability.


See also:

Abbott Laboratories Financial Leverage (Quarterly Data)